Insider Transactions Reported by 12 Insiders of Phio Pharmaceuticals Corp.

Symbol
PHIO on Nasdaq
Location
King Of Prussia, PA

Insiders trading volume in the past year

Phio Pharmaceuticals Corp. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Robert J. Bitterman Chairman, Pres. & CEO, Director $419,649 +$38,711 +10% 05 Feb 2026
Gerrit Dispersyn President & CEO, Director $320,614 01 Mar 2022
Lisa Cabott Carson Chief Financial Officer $95,880 05 Feb 2026
Robert L. Ferrara Director $82,959 +$10,600 +15% 11 Sep 2025
Patricia A. Bradford Director $46,564 05 Feb 2026
David H. Deming Director $38,556 05 Feb 2026
Curtis Lockshin Director $35,858 05 Feb 2026
Jonathan E. Freeman Director $33,308 05 Feb 2026
H. Paul Dorman Director $30,759 15 Feb 2022
Caitlin Kontulis Secretary & VP Finance & Admin $10,196 01 Mar 2024
Robert M. Infarinato Vp, Cfo $8,140 11 Sep 2024
Geert Cauwenbergh Director $6,395 17 Feb 2023

Recent Insider Transactions by Companies or Individuals for Phio Pharmaceuticals Corp.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Curtis Lockshin PHIO Common Stock, $.0001 par value Award 89.5% 16,600 35,155 05 Feb 2026 Direct
Jonathan E. Freeman PHIO Common Stock, $.0001 par value Award 103.4% 16,600 32,655 05 Feb 2026 Direct
David H. Deming PHIO Common Stock, $.0001 par value Award 170% 23,800 37,800 05 Feb 2026 Direct
Lisa Cabott Carson PHIO Common Stock, $.0001 par value Award 100% 47,000 94,000 05 Feb 2026 Direct
Patricia A. Bradford PHIO Common Stock, $.0001 par value Award 68.1% 18,500 45,651 05 Feb 2026 Direct
Robert J. Bitterman PHIO Common Stock, $.0001 par value Award 41.2% 120,000 411,421 05 Feb 2026 Direct
Robert J. Bitterman PHIO Common Stock, $.0001 par value Purchase 1.75% $5,150 $1.03 5,000 291,421 31 Dec 2025 Direct
Robert J. Bitterman PHIO Common Stock, $.0001 par value Purchase 1.78% $5,100 $1.02 5,000 286,421 23 Dec 2025 Direct
Robert J. Bitterman PHIO Common Stock, $.0001 par value Purchase 1.81% $5,700 $1.14 5,000 281,421 21 Nov 2025 Direct
Robert J. Bitterman PHIO Common Stock, $.0001 par value Purchase 1.84% $6,350 $1.27 5,000 276,421 18 Nov 2025 Direct
Robert L. Ferrara PHIO Common Stock, $.0001 par value Award 147.4% 23,100 38,766 11 Sep 2025 Direct
David H. Deming PHIO Common Stock, $.0001 par value Award 14,000 14,000 11 Sep 2025 Direct
Curtis Lockshin PHIO Common Stock, $.0001 par value Award 687.9% 16,200 18,555 11 Sep 2025 Direct
Jonathan E. Freeman PHIO Common Stock, $.0001 par value Award 1084.9% 14,700 16,055 11 Sep 2025 Direct
Lisa Cabott Carson PHIO Common Stock, $.0001 par value Award 47,000 47,000 11 Sep 2025 Direct
Patricia A. Bradford PHIO Common Stock, $.0001 par value Award 225.1% 18,800 27,151 11 Sep 2025 Direct
Robert J. Bitterman PHIO Common Stock, $.0001 par value Award 1167.1% 250,000 271,421 11 Sep 2025 Direct
Robert J. Bitterman PHIO Common Stock, $.0001 par value Tax liability -16.1% -4,111 21,421 11 Sep 2025 Direct
Robert J. Bitterman PHIO Common Stock, $0.0001 par value Purchase 7.95% $4,840 $2.42 2,000 27,149 10 Jun 2025 Direct
Robert L. Ferrara PHIO Common stock, $0.0001 par value Purchase 19% $6,050 $2.42 2,500 15,666 10 Jun 2025 Direct
Robert J. Bitterman PHIO Common Stock, $0.0001 par value Purchase 6.34% $4,125 $2.75 1,500 25,149 09 Jun 2025 Direct
Robert J. Bitterman PHIO Common Stock, $0.0001 par value Purchase 5.35% $2,136 $1.78 1,200 23,649 22 May 2025 Direct
Robert J. Bitterman PHIO Common Stock, $0.0001 par value Purchase 15.4% $5,310 $1.77 3,000 22,449 21 May 2025 Direct
Robert L. Ferrara PHIO Common stock, $0.0001 par value Purchase 23.4% $4,550 $1.82 2,500 13,166 20 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.